GIP Hormone Reduces Inflammation-Induced Nausea Through CGRP Brain Circuits
GIP receptor activation suppressed both inflammation-driven food aversion (via CGRP neurons) and food intake through separate brain circuits.
Quick Facts
What This Study Found
GIP receptor agonism blocks IL-1β-induced aversion via parabrachial CGRP neurons while preserving anorexia through a separate circuit.
Key Numbers
Mouse study; IL-1-beta used to induce inflammation; parabrachial CGRP neurons required for CTA but not anorexia; dorsal vagal complex GIPR required for anorexia but not anti-aversion.
How They Did This
Preclinical mouse study using GIP agonists, IL-1β challenge, in vivo CGRP neuron activity recording, and circuit-specific manipulations.
Why This Research Matters
Understanding how GIP separates nausea from appetite suppression could explain why tirzepatide causes less nausea than pure GLP-1 drugs.
The Bigger Picture
This explains a key advantage of GIP/GLP-1 dual agonists — the GIP component may reduce the nausea that limits GLP-1-only drug tolerability.
What This Study Doesn't Tell Us
Preprint — not yet peer-reviewed. Mouse study may not fully translate to human experiences of nausea and appetite.
Questions This Raises
- ?Does this explain why tirzepatide has fewer GI side effects than semaglutide?
- ?Could selective GIP agonism be used specifically to treat chemotherapy-induced nausea?
Trust & Context
- Key Stat:
- Distinct circuits GIP agonism separates anti-aversion (via CGRP neurons) from appetite suppression through different brain pathways
- Evidence Grade:
- Preprint of a preclinical study — compelling mechanistic data but awaiting peer review and human translation.
- Study Age:
- Preprint posted in 2025, providing cutting-edge mechanistic insight into dual-incretin pharmacology.
- Original Title:
- GIP receptor agonism suppresses inflammation-induced aversion and food intake via distinct circuits.
- Published In:
- bioRxiv : the preprint server for biology (2025)
- Authors:
- Province, Haley S, Hayes, Nikolas W(2), Leong, Nathan A, Lorch, Carolyn M, Pekerman, Alexandra, Xia, Jessica L, Beutler, Lisa R
- Database ID:
- RPEP-13117
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why does tirzepatide cause less nausea than semaglutide?
This study suggests the GIP component of tirzepatide specifically blocks nausea-related brain circuits (CGRP neurons) while preserving appetite suppression.
What are parabrachial CGRP neurons?
Brain cells that produce CGRP and control feelings of sickness, food aversion, and nausea — they are a key target for reducing treatment-related nausea.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-13117APA
Province, Haley S; Hayes, Nikolas W; Leong, Nathan A; Lorch, Carolyn M; Pekerman, Alexandra; Xia, Jessica L; Beutler, Lisa R. (2025). GIP receptor agonism suppresses inflammation-induced aversion and food intake via distinct circuits.. bioRxiv : the preprint server for biology. https://doi.org/10.1101/2025.08.12.669936
MLA
Province, Haley S, et al. "GIP receptor agonism suppresses inflammation-induced aversion and food intake via distinct circuits.." bioRxiv : the preprint server for biology, 2025. https://doi.org/10.1101/2025.08.12.669936
RethinkPeptides
RethinkPeptides Research Database. "GIP receptor agonism suppresses inflammation-induced aversio..." RPEP-13117. Retrieved from https://rethinkpeptides.com/research/province-2025-gip-receptor-agonism-suppresses
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.